Key Dates

Related Announcements

• October 10, 2024 - NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed). See NOFO RFA-CA-24-033.

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold two public pre-application webinars for the Notice of Funding Opportunity (NOFO) RFA-CA-24-033 entitled “NCI National Clinical Trials Network - Network Group Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)". The first webinar will be on Monday, October 28, 2024 from 3:00 - 4:30 p.m. (EST) and the second webinar will be on Tuesday, November 12, 2024 from 4:00 - 5:30 p.m. (EST). NCI staff members involved in this NOFO will provide orientation and technical assistance to potential applicants by explaining the goals and objectives of the National Clinical Trials Network (NCTN) Network Lead Academic Participating Sites and answering questions from attendees about the NCTN Program. Potential applicants are encouraged to submit their questions to [email protected] in advance of the teleconference. Slides will be available at: https://ctep.cancer.gov/initiativesPrograms/nctn.htm two days following the completion of this webinar.

1. To join the webinar on Monday, October 28, 2024 from 3:00 - 4:30 p.m. (EST), follow the link below:

https://cbiit.webex.com/cbiit/j.php?MTID=m6a5da18f211fc6578da937b74aff84df

Meeting number: 2312 435 0513

Meeting password: rjMddQD*532 

Audio for the webinar may be accessed by phoning: 1-650-479-3207

Meeting access number: 2312 435 0513

2. To join the webinar on Tuesday, November 12, 2024 from 4:00 - 5:30 p.m. (EST), follow the link below:

https://cbiit.webex.com/cbiit/j.php?MTID=m4422bfcadbec4a7c17f2d8ed85903ad0

Meeting number: 2313 859 3606 

Meeting password: ykSi75KYP?9

Audio for the webinar may be accessed by phoning: 1-650-479-3207

Meeting access number: 2313 859 3606  

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-24-033.

Inquiries

Please direct all inquiries to:

Margaret Mooney, M.D.
National Cancer Institute (NCI)
Telephone: 240-276-6006 
Email: [email protected]